Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSD | P07339 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2851519 | 0.92 | CTSD (0.35) | CTSD | |
| Formaldehyde SCHEMBL16161196 | 0.90 | CTSD (0.41) | CTSD | |
| Formaldehyde SCHEMBL15319409 | 0.90 | CTSD (0.41) | CTSD | |
| SCHEMBL14954190 | 0.89 | CTSD (0.33) | CTSD | |
| Iodide SCHEMBL810380 | 0.89 | CTSD (0.33) | CTSD | |
| Hydrochloric Acid SCHEMBL23388159 | 0.89 | CTSD (0.33) | CTSD | |
| Fluoride SCHEMBL14954087 | 0.89 | CTSD (0.33) | CTSD | |
| Bromide SCHEMBL809754 | 0.89 | CTSD (0.33) | CTSD | |
| Hydrochloric Acid SCHEMBL810310 | 0.89 | CTSD (0.33) | CTSD | |
| Bicarbonate SCHEMBL29009439 | 0.85 | CTSD (0.33) | CTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4591122-A1 | BAKE-SENSITIVE UNDERLAYERS TO REDUCE DOSE TO SIZE OF EUV PHOTORESIST | Lam Research Corporation (US) | 2025-07-30 | — | — | EP | disclosed |
| WO-2024064071-A1 | BAKE-SENSITIVE UNDERLAYERS TO REDUCE DOSE TO SIZE OF EUV PHOTORESIST | LAM RESEARCH CORPORATION (US) | 2024-03-28 | — | — | WO | disclosed |
| US-9758499-B2 | Stereo controlled synthesis of (E,Z)-dienals via tandem Rh(I) catalyzed propargyl claisen rearrangement | The Florida State University Research Foundation, Inc. (US) | 2017-09-12 | — | — | US | disclosed |
| US-20170129865-A1 | STEREO CONTROLLED SYNTHESIS OF (E,Z)-DIENALS VIA TANDEM RH(I) CATALYZED PROPARGYL CLAISEN REARRANGEMENT | The Florida State University Research Foundation, Inc. | 2017-05-11 | — | — | US | disclosed |
| US-9573871-B2 | Stereo controlled synthesis of (E,Z)-dienals via tandem Rh(I) catalyzed propargyl claisen rearrangement | The Florida State University Research Foundation, Inc. (US) | 2017-02-21 | — | — | US | disclosed |
| EP-2537839-B1 | B-DIHYDROFURAN DERIVING COMPOUND, METHOD FOR PRODUCING B-DIHYDROFURAN DERIVING COMPOUND OR B-TETRAHYDROFURAN DERIVING COMPOUND, B -GLYCOSIDE COMPOUND, METHOD FOR PRODUCING B-GLYCOSIDE COMPOUND, AND METHOD FOR PRODUCING 4'-ETHYNYL D4T AND ANALOGUE COMPOUNDS THEREOF | NISSAN CHEMICAL IND LTD (JP) | 2016-12-14 | — | — | EP | disclosed |
| US-20150361019-A1 | STERO CONTROLLED SYNTHESIS OF (E,Z)-DIENALS VIA TANDEM RH(I) CATALYZED PROPARGYL CLAISEN REARRANGEMENT | The Florida State University Research Foundation, Inc. | 2015-12-17 | — | — | US | disclosed |
| US-9212174-B2 | Certain β-dihydrofuran derivatives | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2015-12-15 | — | — | US | disclosed |
| EP-2537851-B1 | PROCESS FOR PREPARATION OF B-GLYCOSIDE COMPOUNDS | NISSAN CHEMICAL IND LTD (JP) | 2015-06-10 | — | — | EP | disclosed |
| US-8975394-B2 | Process for preparation of β-glycoside compounds | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2015-03-10 | — | — | US | disclosed |
| US-20100197938-A1 | Process for producing indole compoud | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-08-05 | — | — | US | disclosed |
| US-7732626-B2 | Fused cyclic compounds | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-06-08 | — | — | US | disclosed |
| US-20100004312-A1 | FUSED CYCLIC COMPOUNDS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-01-07 | — | — | US | disclosed |
| US-20070083053-A1 | Process for producing indole compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2007-04-12 | — | — | US | disclosed |
| US-20050267229-A1 | Method for producing poly(methyl methacrylate)-metal cluster composite | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2005-12-01 | — | — | US | disclosed |
| EP-0711760-B1 | METHOD OF ALKYLATING TRIAZINE DERIVATIVE | NISSAN CHEMICAL IND LTD (JP) | 2002-05-15 | — | — | EP | disclosed |
| US-6130332-A | USING A GROUP 8 METAL CATALYST AND ALDEHYDES OR KETONE | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2000-10-10 | — | — | US | disclosed |
| US-5792867-A | Method of alkylating of triazine derivatives | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 1998-08-11 | — | — | US | disclosed |
| EP-0760369-A1 | PROCESS FOR ALKYLATING TRIAZINE DERIVATIVE | NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) | 1997-03-05 | — | — | EP | disclosed |
| EP-0711760-A1 | METHOD OF ALKYLATING TRIAZINE DERIVATIVE | NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) | 1996-05-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170129865-A1 | STEREO CONTROLLED SYNTHESIS OF (E,Z)-DIENALS VIA TANDEM RH(I) CATALYZED PROPARGYL CLAISEN REARRANGEMENT | EPRS1, DHPS, RPL14 | CTSD 1679/4885 |
| US-20150361019-A1 | STERO CONTROLLED SYNTHESIS OF (E,Z)-DIENALS VIA TANDEM RH(I) CATALYZED PROPARGYL CLAISEN REARRANGEMENT | EPRS1, DHPS, LSS | CTSD 2658/4885 |
| US-20100004312-A1 | FUSED CYCLIC COMPOUNDS | GPR119, GLP1R, GPR65 | CTSD 3140/4885 |
| US-20100197938-A1 | Process for producing indole compoud | IDO1, IDO2, NOS2 | CTSD 526/4885 |
| US-20070083053-A1 | Process for producing indole compound | IDO2, IDO1, TDO2 | CTSD 2830/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.